These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29179455)

  • 1. Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia.
    Fu S; Xu H; Gu M; Liu C; Wan X; Chen Y; Chen Q; Zhou J; Wang Z
    Oncotarget; 2017 Oct; 8(51):88537-88551. PubMed ID: 29179455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.
    Fu S; Xu H; Gu M; Liu C; Wang Q; Wan X; Chen Y; Chen Q; Peng Y; Cai Z; Zhou J; Wang Z
    Sci Rep; 2017 Mar; 7():43771. PubMed ID: 28256562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study.
    Michalakis K; Williams CJ; Mitsiades N; Blakeman J; Balafouta-Tselenis S; Giannopoulos A; Mantzoros CS
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):308-13. PubMed ID: 17301264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway.
    Xu H; Fu S; Chen Y; Chen Q; Gu M; Liu C; Qiao Z; Zhou J; Wang Z
    Clin Sci (Lond); 2017 Apr; 131(7):595-607. PubMed ID: 28130436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C; Du X; Yang R; Liu J; Xu D; Shi J; Chen L; Shao R; Fan G; Gao X; Tian G; Zhu Y; Zhang J
    J Steroid Biochem Mol Biol; 2015 Jan; 145():28-37. PubMed ID: 25290459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
    Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J
    J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia.
    Castro P; Xia C; Gomez L; Lamb DJ; Ittmann M
    Prostate; 2004 Jul; 60(2):153-9. PubMed ID: 15162381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia.
    Xu D; Chen P; Xiao H; Wang X; DiSanto ME; Zhang X
    Front Endocrinol (Lausanne); 2019; 10():4. PubMed ID: 30728806
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men - a cross-sectional study.
    Tewari R; Rajender S; Natu SM; Goel A; Dalela D; Goel MM; Tondon P
    Cytokine; 2013 Aug; 63(2):130-4. PubMed ID: 23669251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
    Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
    Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin inhibits VEGF-A in prostate cancer cells.
    Gao Q; Zheng J; Yao X; Peng B
    Tumour Biol; 2015 Jun; 36(6):4287-92. PubMed ID: 25586350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of caspase-1 in benign hyperplastic prostate tissues].
    Deng CH; Zang ZJ; Sun XZ; Huang XH; Wang H; Wang D; Su SH
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):810-2. PubMed ID: 16333955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia.
    Xie C; Sun X; Chen J; Ng CF; Lau KM; Cai Z; Jiang X; Chan HC
    J Cell Physiol; 2015 Aug; 230(8):1906-15. PubMed ID: 25546515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.